Hepatocellular Carcinoma (HCC) CHD4: new Target for molecular Therapies

被引：0
|
作者：
Franke, Katharina
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2016年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [1] New molecular therapies for hepatocellular carcinoma
    Torrecilla, S.
    Llovet, J. M.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 : S80 - S85
  • [2] Emerging Therapies for Hepatocellular Carcinoma (HCC)
    Chakraborty, Eesha
    Sarkar, Devanand
    CANCERS, 2022, 14 (11)
  • [3] An siRNA screen identifies CHD4 as a target for epigenetic therapy
    Okamoto, Yasuyuki
    Yamazaki, Jumpei
    Sato, Takahiro
    Cesaroni, Matteo
    Chung, Woonbok
    Garriga, Judith
    Jelinek, Jaroslav
    Katz, Richard A.
    Issa, Jean-Pierre
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Chromatin Remodulator CHD4: A Potential Target for Cancer Interception
    Goswami, Krishnendu
    Venkatachalam, Karthikkumar
    Singh, Surya P.
    Rao, Chinthalapally V.
    Madka, Venkateshwar
    GENES, 2025, 16 (02)
  • [5] Hepatocellular carcinoma (HCC): Current and evolving therapies
    Gish, Robert G.
    Baron, Ari
    IDRUGS, 2008, 11 (03) : 198 - 203
  • [6] Molecular Therapies in Hepatocellular Carcinoma: What Can We Target?
    Galuppo, Roberto
    Ramaiah, Dinesh
    Ponte, Oscar Moreno
    Gedaly, Roberto
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (08) : 1688 - 1697
  • [7] Molecular Therapies in Hepatocellular Carcinoma: What Can We Target?
    Roberto Galuppo
    Dinesh Ramaiah
    Oscar Moreno Ponte
    Roberto Gedaly
    Digestive Diseases and Sciences, 2014, 59 : 1688 - 1697
  • [8] Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia
    Heshmati, Yaser
    Turkoez, Goezde
    Harisankar, Aditya
    Linnarsson, Sten
    Dimitriou, Marios
    Sinha, Indranil
    Lehmann, Soeren
    Qian, Hong
    Walfridsson, Julian
    BLOOD, 2016, 128 (22)
  • [9] The chromatin remodeler CHD4 as a potential specific target for alveolar rhabdomyosarcoma therapy
    Marques, Joana
    Boehm, Maria
    Wachtel, Marco
    Schaefer, Beat
    CANCER RESEARCH, 2016, 76
  • [10] Disrupting chromatin architecture: The NuRD subunit and ATPase CHD4 as a new therapeutic target in pediatric sarcoma.
    Marques, Joana G.
    Gryder, Berkley
    Pavlovic, Blaz
    Chung, Yeonjoo
    Quy Ngo
    Wachtel, Marco
    Khan, Javed
    Schafer, Beat
    CANCER RESEARCH, 2020, 80 (23)
12345